Exploration of New Aromatase Inhibitors as Treatment Options for Breast Cancer: A Study on Molecular Docking, Molecular Dynamics Simulations, and ADMET Analysis - Takeaways - MDSpire

Exploration of New Aromatase Inhibitors as Treatment Options for Breast Cancer: A Study on Molecular Docking, Molecular Dynamics Simulations, and ADMET Analysis

  • By

  • Olayinka Abraham Ojedele

  • Norah Hamdi

  • Mohammed H. AL Mughram

  • Esmael M. Alyami

  • Mohammed Dauelbait

  • Omar A. Almohammed

  • November 25, 2025

  • 0 min

Share

  • 1

    Breast cancer is the most prevalent cancer in women, with approximately 2 million new cases and 500,000 deaths annually worldwide.

  • 2

    Aromatase is a key therapeutic target in breast cancer treatment, mediating estrogen synthesis and influencing tumorigenesis.

  • 3

    Newer aromatase inhibitors like letrozole and anastrozole have improved profiles but still face issues like drug resistance and side effects.

  • 4

    Ricinus communis contains bioactive compounds that exhibit anti-proliferative effects against breast cancer cell lines MCF-7 and MDA-MB-231.

  • 5

    Computer-aided drug design (CADD) is utilized to identify novel compounds from R. communis that may inhibit aromatase and offer new treatment options.

Original Source(s)

Exploration of New Aromatase Inhibitors as Treatment Options for Breast Cancer: A Study on Molecular Docking, Molecular Dynamics Simulations, and ADMET Analysis

  • by Olayinka Abraham Ojedele, Norah Hamdi, Mohammed H. AL Mughram, Esmael M. Alyami, Mohammed Dauelbait, Omar A. Almohammed

  • November 25, 2025

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review